SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $13.5 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 8 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.

The drug developer posted revenue of $29.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $23.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News